entertainment -WSS

entertainment

author：explore 2025-09-27 15:19:38 - browse：87

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Why you get paid to donate plasma but not blood

knowledge

WSS

Researchers use wearables data and AI to predict preterm birth risk

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Address the ethical violations that led to 'Three Identical Strangers'

FDA advisers vote against ALS treatment from BrainStorm

FDA seeks to regulate lab

Twill hunts for pharma partner to market its depression app

hotspot

entertainment

The need-to-know this morning

Is it time to worry about Moderna?

focus

Guidelines to prevent youth baseball injuries need more muscle

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

DIEP, the 'gold standard' of breast reconstruction, is under threat

Address the ethical violations that led to 'Three Identical Strangers'

Medicare proposal to cover medical devices draws a mixed reaction

FDA advisers vote against ALS treatment from BrainStorm

DIEP, the 'gold standard' of breast reconstruction, is under threat

WHO recommends dropping component of many flu vaccines

ChatGPT in medicine: STAT answers readers' burning questions

Lack of darker skin in textbooks, journals harms patients of color

leisure time

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Biogen shutters digital health group, ends Apple study, in cost cutting move

Twill hunts for pharma partner to market its depression app

Biogen shutters digital health group, ends Apple study, in cost cutting move

After a drawn out lobbying fight, ARPA

How the Dana

knowledge

leisure time

knowledge

Wikipedia